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Type 2 diabetes mellitus (T2DM) is a metabolic disorder associated with obesity and hyperglycemia. 
Roux-en-Y gastric bypass (RYGB) surgery is a common treatment for severely obese patients and T2DM. 
Both RYGB and T2DM are linked to increased skeletal fragility, though the exact mechanisms are poorly 
understood. Our aim was to characterize the structural, mechanical and compositional properties of 
bones from diet-induced obese and RYGB-treated obese (bypass) mice to elucidate which the exact 
factors are contributing to the increased skeletal fragility. To achieve this, a combinatory approach 
including microfocus X-ray computed tomography, 3-point bending, finite element modeling and 
Raman spectroscopy, was used. Compared to aged-matched lean controls, the obese mice displayed 
decreased cortical thickness, trabecular bone loss, decreased stiffness and increased Young’s modulus. 
For the bypass mice, these alterations were even more pronounced, and additionally they showed low 
mineral-to-matrix ratio in the cortical endosteal area. Accumulation of the advanced glycation end-
product (AGE) pentosidine was found in the cortex of obese and bypass groups and this accumulation 
was correlated with an increased Young’s modulus. In conclusion, we found that the increased fracture 
risk in T2DM- and post-RYGB bones is mainly driven by accumulation of AGEs and macro-structural 
alterations, generating biomechanical dysfunctionality.
Obesity is a complex disorder that has become an epidemic of great impact in our society. It is the result of 
imbalanced food intake and energy expenditure1. Type 2 diabetes mellitus (T2DM) is one of the most common 
comorbidities resulting from obesity, and is characterized by hyperglycemia, through insulin resistance and islet 
β-cell dysfunction2. T2DM is also known to affect bone homeostasis and quality, to decrease bone strength3 and to 
increase fracture risk4. Gastric bypass surgery is a valuable approach for the treatment of patients suffering from 
T2DM and obesity, resulting in reversal of the hyperglycemia, and rapid and significant weight loss5. Currently, 
the Roux-en-Y gastric bypass (RYGB) procedure has been associated with the most effective drop in bodyweight 
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and a higher remission of diabetes, compared to other procedures such as laparoscopic gastric banding and life-
style intervention6,7. In spite of these benefits, complications such as calcium malabsorption, bone loss, altered 
cortical and trabecular structure, decreased failure load and increased fracture risk have been reported8–10.
Clinical research has indicated that, despite a normal or high bone mineral density, fracture risk in T2DM 
patients is significantly higher at locations such as the hip and vertebrae, compared to non-diabetic subjects11,12. 
Skeletal fragility is determined by bone quality, which comprises material, mechanical and structural properties 
of the bone tissue13. An early study from Saito et al. (2006) demonstrated that bone quality is compromised in 
T2DM WBN/Kob rats through deterioration in the material properties of their bones. The authors showed the 
accumulation of pentosidine, an advanced glycation end-product (AGE) agent, in the femora of the rodents14. 
AGEs are generated by excessive non-enzymatic cross-linking of the collagen, known to negatively influence the 
material and mechanical properties of bone tissue through stiffening of the matrix and hindering processes such 
as bone mineralization14–17. Moreover, it was also highlighted in the study that after 3-point bending mechanical 
tests, the ultimate load, stiffness and work-to-failure of the T2DM femora were significantly decreased com-
pared to non-diabetic controls, evidencing compromised mechanical properties and increased fracture risk under 
T2DM conditions14. Likewise, estimated bone strength in terms of ultimate load was found decreased in mor-
bidly obese patients that underwent RYGB surgery9. It was suggested that the poor mechanical performance 
of the RYGB bone is a consequence of compromised structural properties post-surgery, specifically decreased 
cortical thickness, low trabecular number and increased trabecular separation9. Compromised bone structural 
properties, determined by means of microfocus computed tomography (microCT), have also been reported for 
C57BL/6 mice models of high-fat diet-induced T2DM18,19, and these properties have been previously associated 
with decreased bone mechanical properties20,21.
Furthermore, it has been previously demonstrated that the molecular composition also plays a role in the 
quality and biomechanical behavior of bone tissue22. In ageing Sprague-Dawley rats and baboons, the indenta-
tion modulus and hardness of femora were correlated with Raman microspectroscopy-based mineral-to-matrix 
and carbonate-to-phosphate ratios, contributing to the detriment of biomechanical behavior of bone23,24. These 
studies demonstrated that bone composition and intrinsic mechanical properties are interrelated and negatively 
influenced by ageing effects.
Despite the current knowledge on the impact of T2DM and RYGB surgery on bone tissue properties and frac-
ture risk, the exact causes of these detrimental effects are still not well understood. Therefore, the main objective 
of this study was to characterize bone’s structural, mechanical and compositional properties and to decipher the 
exact factors causing the compromised bone quality and increased fracture risk under T2DM- and post-RYGB 
conditons. In order to achieve this, a combinatory approach by means of both experiments and computational 
modeling was adopted.
Results
Physiological characteristics altered by T2DM and RYGB. After 22 weeks of high-fat diet treatment, 
the obese mice displayed a significant increase in bodyweight and fasting blood glucose compared to lean controls 
(Fig. 1), indicating obesity-driven T2DM conditions with poor glucose handling. The bypass mice showed similar 
bodyweight and glycemia values compared to lean control animals, though all significantly reduced compared 
to their obese counterparts. When young and lean mice were compared, the latter displayed significantly higher 
bodyweight and similar blood glucose levels.
Cortical and trabecular bone architecture are compromised by T2DM and RYGB. To investigate 
the role of the macro-structure in the skeletal fragility of our obese and bypass mice, the cortical and trabecular 
compartments of the femora were evaluated by means of microCT. Ct.Th was found to be significantly decreased 
in obese mice compared to lean mice and an even lower thickness was observed in bypass mice compared to 
both previous groups (Fig. 2). It is important to highlight that, relative to lean controls, the obese group showed a 
Figure 1. (a) Bodyweight and (b) fasting glycemia of young, lean, obese and bypass mice. §§§p < 0.001 when 
comparing the young and age-matched lean group; ***p < 0.001 when comparing the obese, lean and bypass 
groups. n = 6/group.
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decreased Ct.OtD and the bypass group presented an increased Ct.InD, indicating impairment of the bone appo-
sition process for both mice groups. Regarding the ageing effect on cortical bone, lean mice showed a significantly 
increased Ct.Th and increased Ct.OtD compared to young animals, though an unchanged Ct.InD.
Relative to lean controls, the trabecular BV/TV was drastically reduced in obese mice and even more so in 
bypass mice (Fig. 3). Additionally, the BV/TV difference between obese and bypass mice reached statistical sig-
nificance (p < 0.05). Furthermore, the trabeculae were the thinnest in bypass animals and presented significantly 
increased Tb.Sp compared to both obese and lean counterparts, all these suggesting potential bone remodeling 
alterations. Femora from young mice had the tendency to be slightly reduced in all trabecular parameters when 
compared to lean controls without reaching statistical significance.
Bone biomechanical and material properties are affected by T2DM and RYGB surgery. In order 
to determine if the observed alterations in the structural properties in both obese and bypass groups were affect-
ing the biomechanical functionality of bone, we assessed the mechanical properties. Obese mice had less stiff 
bones than lean controls, but not less than bypass mice, which showed an extremely low stiffness (Fig. 4a). The 
same results were found for ultimate load (Fig. 4b), revealing that obese and bypass mice possess weaker bones 
compared to controls. Work-to-failure was lower only in bypass mice compared to lean controls (Fig. 4c). Young 
mice had significantly less stiff bones and a decreased ultimate load when compared to their ageing counterparts, 
which was an expected result from the ageing process.
Changes in Young’s modulus of T2DM and RYGB bone are due to increased accumulation of 
AGEs. The material properties of the bones were assessed through the calculation of the Young’s modulus, 
via finite element modeling (Fig. 4d). This parameter was significantly higher for both obese and bypass groups, 
compared to controls, indicating altered material properties of the bone tissue. To corroborate this finding, the 
relative content of the AGEs pentosidine and CML was evaluated using Raman spectroscopy (Fig. 5). Bone tissue 
from obese and bypass animals showed a clear tendency of increased AGEs accumulation in all cortical areas 
assessed, and particularly a significant accumulation of pentosidine in the endosteal and mid-cortical areas of 
both mice groups, compared to lean mice. When the ageing component was evaluated, accumulation of pento-
sidine and CML species tended to be higher in lean animals compared to the young group, but without reaching 
statistical significance.
Compositional characteristics of the endosteal cortex and of trabeculae are altered after RYGB 
surgery. In order to investigate if other bone compositional characteristics of the obese and bypass groups 
were altered, Raman spectroscopy was used again. Obese, bypass and lean groups presented differences in the 
level of mineralization of the Per.S vs Mid.C. Only the bypass group showed significantly lower mineralization 
of the End.S when compared to the Mid.C (Fig. 6). Mineralization did not differ significantly throughout the 
cortex of young animals. Moreover, similar results were obtained for the crystallinity values of all groups’ cortical 
locations (Supplementary Fig. S1), except for the bypass group, which remained uniform among locations. The 
Figure 2. MicroCT-based quantification of the cortical bone structural parameters (upper panels): (a) Ct.Th, 
(b) Ct.InD and (c) Ct.OtD for young, lean, obese and bypass femora. 3D renderings of the cortex of (lower 
panels): (d) young, (e) lean, (f) obese and (g) bypass femora. §§§p < 0.001 when comparing the young and age-
matched lean group; **p < 0.01 and ***p < 0.001 when comparing the obese, lean and bypass groups. n = 6/
group.
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Figure 3. MicroCT-based quantification of the trabecular bone structural parameters (upper panels): (a) BV/
TV, (b) Tb.Th and (c) Tb.Sp of young, lean, obese and bypass mice femora. 3D renderings of the trabecular 
area of (lower panels): (d) young, (e) lean, (f) obese and (g) bypass femora. **p < 0.01 and ***p < 0.001 when 
comparing the obese, lean and bypass groups. n = 6/group.
Figure 4. (a) Bending stiffness, (b) ultimate load, (c) work-to-failure, assessed by three-point bending, and 
(d) Young’s modulus, calculated using finite element analysis, of young, lean, obese and bypass mice femora. 
§§§p < 0.001 when comparing the young and age-matched lean group; *p < 0.05, **p < 0.01, and ***p < 0.001 
when comparing the obese, lean and bypass groups. n = 6/group.
www.nature.com/scientificreports/
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Figure 5. Relative content of the advanced glycation end products (AGEs) pentosidine and CML in periosteal 
(a,d), middle (b,e) and endosteal (c,f) cortical locations, respectively, for young, lean, obese and bypass groups. 
The Raman-specific bands for both AGEs were normalized to the CH2 band, representative of the organic 
matrix. Per.S: Periosteal area, Mid.C: Mid-cortical area; End.S: Endosteal area. *p < 0.05 and **p < 0.01 when 
comparing the obese, lean and bypass groups. n = 6/group.
Figure 6. Raman-based mineral-to-matrix ratio at periosteal, middle and endosteal intracortical locations 
of (a) young, (b) lean, (c) obese and (d) bypass femora. 10 point scans were made per cortical location. Per.S: 
Periosteal area, Mid.C: Mid-cortical area; End.S: Endosteal area. *p < 0.05; **p < 0.01; ***p < 0.001 when 
comparing the obese, lean and bypass groups. n = 6/group.
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carbonate-to-phosphate ratio did not vary significantly between any of the locations of the studied groups, except 
for bypass animals, which showed significantly lower carbonate substitutions in the End.S compared to Mid.C 
(Supplementary Fig. S1). When comparing Raman-based parameters per cortical location between groups (Fig. 7 
and Supplementary Fig. S2), the bypass group presented a significantly lower mineral-to-matrix ratio in the End.S 
when compared to both lean and obese groups. Relative to the obese group, the crystallinity was lower in the 
End.S of bypass bones. Mineralization, carbonate substitutions and crystallinity of both lean and obese groups 
were similar at all cortical locations (Fig. 7 and Supplementary Fig. S2), indicating that T2DM does not impact 
the bone compositional properties significantly. Mineral-to-matrix and crystallinity were significantly lower in 
the Mid.C and End.S locations of the young group compared to lean controls.
Regarding the trabecular area (Fig. 7), the carbonate-to-phosphate ratio of bypass and obese groups was sig-
nificantly lower than in lean controls (p < 0.01). In addition, similar to the cortical area, all physico-chemical 
parameters of the trabecular bone were increased with ageing, but only crystallinity reached significance.
PLS-DA showed a clear separation of the spectra between young and lean controls for each area assessed 
(Supplementary Fig. S3). For all bone areas, the carbonate peak was associated with the lean group. Similarly, the 
young group was mainly associated with the organic phase (Amide I, Amide III and CH2). Furthermore, no clear 
separation of Raman spectra could be observed between obese vs lean, obese vs bypass and bypass vs lean groups 
(Supplementary Fig. S4).
Bone mechanical properties are correlated with macro-architectural parameters - Young’s 
modulus correlates with pentosidine content. Correlation analyses revealed that both ultimate load 
and stiffness were correlated with the Ct.Th and Tb.Th in the femora, while work-to-failure correlated positively 
with trabecular BV/TV, but negatively with Tb.Sp (Table 1). Moreover, the Young’s modulus was found to be 
positively correlated with the content of pentosidine and almost reached significance with CML accumulation 
(p = 0.07). These data indicate that both structural and material properties have an impact on bone mechanical 
performance under T2DM and post-RYGB conditions. Other material and compositional parameters assessed in 
this study were tested for correlations, but no statistical significance was found in any of the cases.
Discussion
High-fat diet-induced T2DM generates many severe complications, including skeletal deterioration. Given 
that RYGB surgery has become the most commonly performed bariatric procedure against morbid obesity and 
T2DM25,26, but has also shown to negatively impact the skeleton, our aim was to determine the possible factors 
associated with T2DM and subsequent RYGB surgery, leading to deterioration of bone quality and increased 
Figure 7. Differences in Raman-based (a) mineral-to-matrix ratio, (b) carbonate-to-phosphate ratio and (c) 
crystallinity at the endosteal cortical location and (d) mineral-to-matrix ratio, (e) carbonate-to-phosphate 
ratio and (f) crystallinity of the trabeculae of mice femora between young, lean, obese and bypass mice. End.S: 
Endosteal area. §§§p < 0.001 when comparing the young and age-matched lean group; *p < 0.05 and **p < 0.01, 
when comparing the obese, lean and bypass groups. n = 6/group.
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fracture risk. To achieve this, structural, mechanical and compositional bone characteristics were assessed in both 
T2DM and RYGB mouse models.
The assessment of the bone structural characteristics after microCT scanning revealed no osteopenic pheno-
type in lean controls when compared to the young group. On the contrary, we could see only slightly increased 
Tb.Th, Tb.S, and in contrast to literature27,28, mildly increased trabecular BV/TV. We did observe a physiological 
age-related pattern of bone growth, significant thickening of the cortex and expansion of the periosteal surface, 
where bone apposition mainly occurs in normal ageing conditions28,29. In the case of obese and bypass mice, the 
macro-architecture was noticeably altered, evidenced by the thinning of the cortex for both groups. Interestingly, 
compared to lean controls, the periosteal surface seemed to be diminished in the obese group (lower Ct.OtD), 
contrary to bypass bones where the endosteal surface was decreased (increased Ct.InD), implying compromised 
bone expansion in each case. Alterations in bone architecture after RYGB surgery were recently reported, evi-
dencing reduced cortical area in RYGB patients30, supporting our results. After in vivo ulnar loading applied to 
C57BL/6-Ins2Akita/J (Akita) mice (type 1 diabetes model), another study revealed that periosteal bone forma-
tion rate was compromised31, in line with the results of our obese mice. The role of osteocytes was particularly 
highlighted by the authors, as it appears that the mechanosensory response of these cells is compromised under 
diabetic conditions, thus generating bone turnover alterations in the periosteum31.
A previous study from our group demonstrated that obese, T2DM mice showed decreased serum levels of 
bone turnover biomarkers C-terminal telopeptide of type I collagen (CTX) and osteocalcin (OCN)32. Meanwhile, 
several studies agree that the expression levels of CTX, OCN and/or P1NP in bone are affected after gastric 
bypass33,34. The suggested alteration of the bone remodeling of both mice groups goes in line with the dramatic 
decrease of trabecular BV/TV found in this study, given the fact that the trabecular compartment is an area more 
metabolically active than the cortex, and prone to high levels of remodeling35.
In this regard, bone turnover markers can be directly altered by variations in the bodyweight of a subject. In 
the case of our obese mice, a decreased Ct.OtD indicates that the potential influence of the increase in mechanical 
loading due to the increased weight is not sufficient to trigger mechanisms favoring the formation of new bone 
tissue36. In contrast to the obese group, bypass mice experienced a drastic weight loss, hence a sudden mechanical 
unloading. This has the capacity to make bone adapt to the decline in mechanical stress by increasing remod-
eling37,38. The lack of an energy-restricted control group is a limitation of our study, since it is difficult to assert 
that the bone loss observed in our bypass mice is either dependent or independent of weight loss. Nevertheless, 
there have been several studies in literature reporting that bone loss, evidenced as decreased BMD at the hip (a 
weight-bearing location), is associated with weight loss after RYGB surgery30,39.
Furthermore, it has been previously reported that the presence of AGEs has a negative impact on the oste-
ogenic potential and osteoclastogenesis of progenitor cells. Using human osteoblasts exposed to AGEs in vitro, 
Franke et al. (2011) demonstrated low expression of alkaline phosphate and OCN, affecting osteoblastic function 
and differentiation, and increased RANKL expression, favoring the generation of osteoclastic cells40. These data 
suggest that the accumulation of AGEs found in our obese and bypass mice can contribute to the observed bone 
loss, through loss of progenitors’ osteogenic potential and enhancement of bone resorption.
Another factor contributing to bone loss through alterations of bone remodeling in our bypass mice can be the 
nutrients malabsorption caused by the surgery itself. This has been reported before to cause detrimental effects on 
bone volume and bone cellular homeostasis34,41. Elevated expression of PTH (secondary hyperparathyroidism) 
caused by poor calcium and vitamin D uptake can generate skeletal calcium mobilization to the blood stream in 
order to stabilize the levels of calcium intestinal absorption, favoring bone resorption42,43. All these mechanisms 
(potentially) triggering bone resorption in our bypass mice suggest that the bone loss process is multifactorial.
Despite this assertion, the lack of a sham-surgery control group represents an extra limitation of our 
study. Nonetheless, studies in literature have proven that, compared to sham controls, bypass rats showed 
RYGB-associated bone resorption, with increased expression of CTX, decreased expression of P1NP, and com-
promised bone structural properties, evidenced as lower trabecular volume, number, thickness, lower cortical 
volume and thickness34.
In this regard, changes of the structural properties, triggered by the impairment of the bone resorption and 
formation processes, suggest alterations of biomechanical properties and an influence on bone strength44. Among 
the mechanical parameters assessed in this study, the bending stiffness is a parameter closely related to the miner-
alization of bone tissue36. Therefore, it was anticipated to find the femora of young mice less stiff than those of the 
lean controls45. Poorly mineralized bones with low stiffness are expected to have a high ductility36. Even though 
Mechanical/Material
Macro-architectural AGEs
Ct.Th BV/TV Tb.Th Tb.Sp Pentosidine CML
Ultimate load 0.987* NS 0.961* NS NS NS
Work-to-failure NS 0.991** NS −0.950* NS NS
Stiffness 0.985* NS 0.994** NS NS NS
Young’s modulus NS NS NS NS 0.993** NS (0.07)
Table 1. Correlations of the mechanical and material parameters with the bone’s architecture and AGEs content 
assessed in young, lean, obese and bypass femora. The Pearson correlation coefficient was implemented. Other 
material and compositional parameters assessed in this study were tested for correlations but no statistical 
significance was found in any of the cases. For each of the pairings (mechanical/material property parameter 
vs macro-architectural property/AGEs parameter) significance was indicated as *p<0.05; **p<0.01; NS: No 
significance.
www.nature.com/scientificreports/
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the bypass mice femora showed extreme low stiffness, low work-to-failure values relative to lean mice imply a 
reduced ultimate displacement and less amount of energy necessary until the bone breaks. Moreover, the fact that 
ultimate load values are greatly reduced in the bypass group evidences a compromised mechanical performance 
favoring increased risk of fractures. This is in line with a recent study showing after finite element analysis a 
decrease in estimated stiffness and ultimate load caused by the disintegration of the cortical and trabecular bone, 
implying a negative impact on fracture risk in RYGB patients9. On the other hand, the impaired periosteal bone 
apposition found in our study may be reducing the bone strength in the femora of our obese mice, as suggested 
by the reduced ultimate load, compared to lean controls. This, in addition to the significantly decreased stiffness, 
and the tendency of decreased work-to-failure, support the findings of different studies evaluating the mechanical 
performance on mouse models of diabetes46–48. Furthermore, correlations between mechanical and structural 
parameters (Table 1) reflect that the alterations in the macrostructure of both obese and bypass mice femora are 
strongly influencing the mechanical performance of the bone.
The higher Young’s modulus in the obese and bypass groups compared to lean mice is indicative of an 
increased material stiffness. As the 3-point bending test takes into account shape and geometry, finite element 
modeling results suggest that not only the structure but also the material properties are factors responsible for 
the compromised mechanical performance and diminished bone quality in obese and bypass mice. To elucidate 
what could be causing the increased Young’s modulus, the presence of AGEs was evaluated by means of Raman 
microspectroscopy. AGEs accumulation in T2DM bone favors material stiffness and alters bone’s mechanical 
properties14,16,49. Therefore, the elevated levels of AGEs found in our study explain the increase of Young’s modu-
lus in the bones from obese and bypass mice. This is further confirmed by the positive correlation found between 
the Young’s modulus and the pentosidine content in bone tissue. Furthermore, as a consequence of pentosidine 
and CML accumulation, fracture toughness initiation and propagation were found decreased in a mice model 
of type 1 diabetes50. These findings support our results in the obese and bypass groups. Even though the RYGB 
procedure in obese mice was capable of reducing their hyperglycemic state to control levels, the AGEs content 
was still not normalized, and thus improvement of the bone quality was not achieved. This suggests that either 
other processes favoring AGEs accumulation (such as oxidative stress) are still strongly present in bypass mice, or 
that the process of AGEs removal requires an extended period of time, much longer than the 8 weeks post-RYGB 
applied in the present study51.
More parameters related to bone composition at the microscale were analyzed by Raman spectroscopy. Firstly, 
the Raman parameters varied significantly according to the location within the cortex, also reported by previous 
studies23. These differences were present in all mice groups, but to a much less extent in the young group, imply-
ing that notable changes between the locations have not yet manifested. The low mineral and carbonate content 
of young bones are in agreement with previous studies on rodents, baboons and humans45,52,53, evidencing that 
bone composition changes with ageing. PLS-DA confirmed these results, revealing a clear separation of the 2 
groups. The physico-chemical parameters of the cortical locations were highly similar between lean, obese and 
bypass mice. This was confirmed by the lack of separation of the groups after PLS-DA. Together with the lack of 
correlation between Raman-based ratios and mechanical parameters, this suggests that, by itself, the composition 
of bone tissue cannot generate an increased fracture risk in both T2DM subjects and RYGB-intervened subjects, 
but should be seen as a contributor along with other possible detrimental factors. An exception was seen in the 
endosteal surface of the bypass mice femora, where significantly lower mineral-to-matrix ratio and crystallinity 
were observed compared to the bones from lean and obese animals. It is noteworthy that mainly all compositional 
alterations found in the cortex of the bypass group femora correspond to the endosteal location, which was found 
to be severely compromised according to the microstructural analysis.
The high levels of material stiffness (Young’s modulus) despite the lower level of mineralization of the femora 
from the bypass group, further suggests the influence of the AGEs in the stiffening of the tissue. In addition, 
no correlation could be established between the Raman-based ratios and material stiffness in our study. Thus, 
although the endosteal cortical area of the bypass group seemed to be poorly mineralized, other mechanisms dif-
ferent from bone mineralization (like the AGEs accumulation and macro-architectural alterations) must explain 
the increased fracture risk in subjects after RYGB surgery. Likewise, the degree of mineralization measured by 
Raman spectroscopy cannot explain the reduced stiffness calculated by 3-point bending in the obese group, since 
we found no differences of mineral-to-matrix ratio in cortical and trabecular areas of obese mice compared to lean 
controls. This differs with a previous study on Zucker diabetic Sprague-Dawley rats by Hammond et al. (2013), 
which showed increased values of mineral-to-matrix ratio relative to controls54. However, the authors also found 
a decreased ash fraction in obese rats’ tibiae, which led them to discuss the possibility that the T2DM-induced 
accumulation of AGEs was impeding the collagen structure to freely vibrate, reducing the signal of the collagen 
bands and potentially overestimating mineral-to-matrix values. We cannot discard the possibility that this may 
be happening also in our obese and bypass mouse models.
Differences in the rest of the Raman-based parameters were not found between lean and obese mice, imply-
ing that bone composition between these 2 groups is alike. These data support the findings made by Hammond 
et al., showing no significant differences between control and T2DM rats for carbonate-to-phosphate ratio and 
crystallinity54. The only Raman-based parameter that was found to be significantly different between obese and 
lean bone samples in the present study was the carbonate-to-phosphate ratio, lower in the trabecular area of the 
femora from obese mice. As mentioned before, this same area showed trabecular bone loss compared to lean 
animals after microCT scanning. Thus, as previously discussed in this section, it is possible that alterations in the 
process of bone remodeling taking place in the femora of our obese mice are causing changes in the composition 
of the apatite lattice in terms of substitution of carbonate ions.
In conclusion, the observed changes at the cortical periosteal (obese) and endosteal (bypass) surfaces, in addition to 
alterations of the trabecular area, imply that bone turnover abnormalities are taking place in T2DM- and post-RYGB 
bones. These alterations in the bone structural properties are negatively affecting the biomechanical functionality of 
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bones from obese and bypass mice, and thus are increasing the risk of bone fracture in these mice groups. Furthermore, 
bone fracture mechanics are influenced by compromised material properties in both obese and bypass groups due to 
the increased accumulation of AGEs, of which pentosidine was associated with an increased Young’s modulus com-
pared to controls. Overall, the etiology of the increased fracture risk in both T2DM- and RYGB bones appears to be 
mainly driven by material- and macro-structural-influenced biomechanical dysfunctionality.
Materials and Methods
Animals. Animal experimental procedures were performed in accordance with the Belgian legislation, the 
ARRIVE guidelines and the ILAR Guide to the Care and Use of Experimental Animals, and they were approved 
by the Ethics Committee of the University of Leuven (P101/2014). Six-weeks-old male mice, substrain C57BL/6, 
were obtained from Janvier Labs (Le Genest-Saint-Isle, France). Four to 5 mice per cage were housed and allowed 
to acclimatize for 2 weeks before the start of the study. Food and water were available ad libitum. A 12:12 h light-
dark cycle was implemented and room temperature was kept at 22 °C.
Mice were randomly divided into 2 groups, namely a low-fat diet (10 kcal% fat - aged-matched lean group 
(lean), n = 6) and high-fat diet (60 kcal% fat - diet-induced obese group (obese), n = 12) group. The diets 
(Research Diets, Inc. – New Brunswick, NJ, USA – Low-fat diet: D12450-B; High-fat diet: D12492; open source) 
were administered to lean and obese mice for a total period of 22 weeks (age of sacrifice: 30 weeks old), allowing 
the DIO animals to reach a diabetic condition. In order to corroborate that potential changes in the bone proper-
ties of the experimental mice groups are not occurring (solely) due to ageing effects, an additional group of young 
healthy 8-weeks-old mice were added as baseline control (group young, n = 6). At the end of the experiment, 
body weight and glucose levels were determined.
Six obese mice were randomly assigned to a new group after 14 weeks of high-fat diet intake, and were subject 
to RYGB surgery (group bypass). The RYGB surgical procedure was performed under carprofen analgesia (3 µg/g 
bodyweight) and 2–3% isoflurane anesthesia. Briefly, a 2–2.5 cm midline abdominal incision was made and the 
esophagus, stomach and proximal jejunum were dissected using cotton tip applicators and fine scissors or forceps. 
The jejunum was transected 3 cm below the ligament of Treitz and an end-to-side jejunojejunostomy was created 
with a 9–0 nylon separated suture. Next, the stomach was transected, the jejunum brought up to the stomach to 
perform an end-to-side gastrojejunostomy with 9–0 nylon separated suture, creating an alimentary limb. At the 
end, the midline incision was closed and the mice were recovered on a water-circulated heating pad. The mice had 
ad libitum access to water and normal chow diet from postoperative day 1 to 6, where after they were reinstated 
on high-fat diet for 7 additional weeks (age of sacrifice: 30 weeks old), to allow for their recuperation and ensure 
that enough time has passed for the potential effects of the RYGB surgery to take place.
Bone tissue collection. Animals were euthanized by means of carbon dioxide administration. Since fixation 
or embedding of bone samples can alter the compositional properties of the tissue, interfering with the Raman 
bone-related spectral parameters55 or affecting the mechanical properties, we decided to preserve the samples by 
snap-freezing56. Femora were snap-frozen through liquid nitrogen immersion, wrapped in aluminum foil and 
stored at −80 °C.
MicroCT acquisition and image analysis. Left femora (n = 6 per group) were scanned at 8 µm voxel size 
to image the full sample within 1 scan, using the Phoenix NanoTom S (GE Measurement and Control Solutions, 
Germany). The source was set at 60 kV and 210 µA, and an aluminum filter of 0.2 mm was applied. Application of 
the ‘fast mode’ settings (i.e. exposure time 500 ms, frame averaging 1 and skip 0) and acquisition of 2400 radio-
graphs resulted in a scanning time of 20 minutes per sample.
Images were analyzed using CTAn software (Bruker MicroCT, Kontich, Belgium). Two separate areas of the bone 
(cortical and trabecular area) were analyzed. Both areas covered 1.2 mm of bone length (150 cross-sections). For the 
trabecular area, the area started 800 µm below the growth plate and continued downwards. The trabecular structure 
was manually included inside a region of interest (ROI). Firstly, images within the ROI underwent a binarization 
step (Otsu57), followed by noise removal by a closing operation (round kernel, radius 1, 3D space) and a double 
despeckling step (removal of black and white speckles respectively, 3D space, less than 25 voxels), as described 
previously32. 3D analysis of the processed datasets allowed determining the following parameters: trabecular vol-
ume fraction (BV/TV, %), trabecular thickness (Tb.Th, µm) and trabecular separation (Tb.Sp, µm). For the cortical 
area, the area started at the fibula-to-tibia insertion point and continued upwards. The ROI fitting the cortical bone 
was drawn automatically using an in-house developed protocol. After binarization of the cross-sections using Otsu 
segmentation, noise and cortical porosity were removed using despeckling as previously described32. In order to 
determine the cortical thickness (Ct.Th, µm), binarized images went through a process of “skeletonization” based 
on “distance transform” algorithms58 to identify the medial axis of each cross-section, on the model-independent 
technique from Hildebrand and Ruegsegger59. Furthermore, a “sphere-fitting” process59 was carried out for all voxels 
comprising the established axis. Finally, an average value of all fitted spheres was obtained. The same procedure was 
used to determine the cortical outer (Ct.OtD, µm) and cortical inner diameter (Ct.InD, µm), analyzing the binarized 
images with a filled marrow cavity and images of the marrow cavity space, respectively.
Three-point bending test. Bone stiffness, ultimate load and work-to-failure were calculated from load 
versus displacement curves using 3-point bending tests on left femora (n = 6 per group), following a protocol 
described before60. Briefly, testing was performed using the BOSE Test Bench (LM1, EnduraTEC Systems Group, 
Bose Corp., Minnetonka, MN, USA). The span length was 6 mm whereas the radius of curvature of each support 
was 2 mm. The bones were placed with their anterior surface on the two supports and were subjected to a 1 N 
stabilizing preload and 2 conditioning cycles prior to loading until failure at a rate of 0.1 mm/s.
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Finite element analysis. Finite element analyses, simulating the 3-point bending tests, were performed 
based on the microCT data using a validated approach61. Briefly, an automated alignment routine turned the 
reconstructed femora such that their anterior surface was in contact with two supports as in the experimental 
setup described above. Finite element models were created from the aligned femora using a standard voxel con-
version technique, hence, each voxel from the microCT reconstruction was converted to a hexahedral element in 
the finite element model. Boundary conditions mimicking the 3-point bending test were applied61. All elements 
in the finite element models were given an identical, arbitrary tissue modulus of 10 GPa and a Poisson ratio of 
0.3. Assuming linear-elastic material behavior, the models were solved using ParOSol62, a dedicated micro-finite 
element solver running on a supercomputer (CSCS, Lugano, Switzerland). The finite element sample stiffness was 
calculated as the finite element calculated force divided by the prescribed displacement. The bone tissue Young’s 
modulus was determined by linear scaling of the finite element sample stiffness to the experimentally measured 
stiffness63.
Raman spectroscopy. Right femora (n = 6 for each group) were thawed at room temperature and cut in 
half along the longitudinal axis using a diamond saw. Femora were analyzed using Raman microspectrometer 
SENTERRA (Bruker) equipped with a laser of λ = 720 nm. Raman spectra were acquired with a 100× objective 
and a total integration time of 135 sec (45 secs (×3)). The spectral range was 400–1780 cm−1 with a spectral res-
olution of 3–5 cm−1. Baseline correction and peak intensities were done using the OPUS software 7.2 (Bruker).
Mineral-to-matrix ratio determines the mineralization degree of the sample. It was calculated from the ratio 
of the phosphate symmetric stretch band (960 cm−1) to the CH2 band (1450 cm−1). Crystallinity, a measure of the 
size and perfection of the apatite lattice, was calculated as the inverse of the full width at half maximum (FWHM) 
of the phosphate symmetric stretch band, using the OriginPro 2017 software (OriginLab, Massachusetts, USA). 
The carbonate-to-phosphate ratio represents the carbonate substitutions for phosphate positions in bone. 
It was calculated as the ratio of the type-B carbonate band (1070 cm−1) and the phosphate symmetric stretch 
band. The intensities of the Raman-specific bands previously reported for pentosidine (~1495 cm−1) and 
carboxymethyl-lysine (CML; ~1150 cm−1) were obtained and normalized to the CH2 band to evaluate AGEs 
accumulation50.
The physico-chemical variables are dependent on the location in the cortex23. Thus, the cortical bone was ana-
lyzed at 3 specific ROIs (Supplementary Fig. S5): (i) periosteal surface (Per.S), (ii) mid-cortical area (Mid.C) and 
(iii) endosteal surface (End.S). Acquisitions were made at the mid-diaphyseal region. Regarding the trabecular 
bone, acquisitions were performed at the distal epiphysis of the femora. Ten spectra were acquired per cortical 
ROI and 20 spectra in the trabecular area. Each physico-chemical parameter was averaged over the 10–20 spectra 
per ROI for each sample.
Partial least squares discriminant analysis (PLS-DA) was carried out to find the specific Raman spectral fea-
tures and to sharpen the separation between the studied groups. The analysis was done using spectral datasets of 
known class membership composed of 2 known classes (young vs lean, obese vs lean, obese vs bypass and lean 
vs bypass) per ROI (Per.S, Mid.C, End.S, Trabecular), using a methodology previously described64. PLS-DA was 
performed using the PLS Toolbox v6.7 (Eigenvector Research, Inc., Wenatchee, WA, USA) in Matlab (Mathworks 
Inc., Natick, MA, USA).
Statistical analysis. Data for all parameters are expressed as group means ± standard deviation. Analysis 
of normality of the data was performed using the D’Agostino-Pearson test and the presence of outliers was tested 
using the Dixon test. Equality of variances was assumed when the F-test (normally distributed) or Levene’s test 
(not normally distributed) revealed values of p > 0.05. The young group was independently compared to the lean 
group using a two-tailed unpaired t-test (normally distributed) or a Kruskal-Wallis test (not normally distributed) 
with equal or unequal variance depending on the F-test or Levene’s test respectively. Since the obese and bypass 
mouse models need a combination of time (ageing) and diet to generate the skeletal impairments, we cannot 
assume that these factors are truly independent. For this reason, we could not compare these groups with the 
young mice group. For comparison of the obese, lean and bypass groups, a one-way ANOVA test was used. All 
statistical analysis was performed using GraphPad PRISM (GraphPad software, La Joya, CA, USA). Significance 
is indicated in the graphs as follows: §p < 0.05, §§p < 0.01, and §§§p < 0.001 when comparing the young and lean 
group; *p < 0.05, **p < 0.01, and ***p < 0.001 when comparing the obese, lean and bypass groups. In order to 
evaluate correlations between the assessed parameters, a Pearson correlation coefficient test was used for data 
displaying normal distribution with p < 0.05 for significant correlations.
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